Back to top
more

VERADIGM INC (MDRX)

(Delayed Data from OTC)

$7.96 USD

7.96
249,847

+0.01 (0.13%)

Updated Apr 26, 2024 03:59 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (95 out of 252)

Industry: Technology Services

Better trading starts here.

Zacks News

Reasons to Retain Intuitive Surgical (ISRG) Stock For Now

Investors continue to be optimistic about Intuitive Surgical (ISRG) owing to its strength in robotics.

Is Lantheus Holdings (LNTH) Outperforming Other Medical Stocks This Year?

Here is how Lantheus Holdings (LNTH) and AllScripts Healthcare (MDRX) have performed compared to their sector so far this year.

Here's Why You Should Retain BD (BDX) Stock in Your Portfolio

Investors continue to be optimistic about BD (BDX) owing to its slew of product launches and strategic deals.

HealthEquity (HQY) Q4 Earnings Lag Estimates, Margins Down

HealthEquity (HQY) witnesses solid growth in HSAs, along with recording robust Custodial and Interchange revenues, in the fourth quarter of fiscal 2022.

Reasons to Add Allscripts (MDRX) Stock to Your Portfolio

Investors continue to be optimistic about Allscripts Healthcare Solutions (MDRX) owing to its strategic alliances.

Catalent's (CTLT) New Project Completion Expands Global Footprint

Catalent's (CTLT) latest facility transformation is likely to significantly enhance the global Biologics business.

Masimo's (MASI) New Product Expansion to Boost Patient Outcome

Masimo's (MASI) latest feature additions to its telehealth for Patient SafetyNet are likely to significantly improve patient outcomes.

Medtronic (MDT) Boosts Surgical Robotics Wing With New Deal

According to Medtronic (MDT), Touch Surgery Enterprise is the first AI-powered platform of its kind for the operating room (OR). It is compatible with Medtronic's Hugo robotic-assisted surgery (RAS) system.

Surging Earnings Estimates Signal Upside for AllScripts (MDRX) Stock

AllScripts (MDRX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Reasons to Add AMN Healthcare (AMN) Stock to Your Portfolio

Investors remain optimistic about AMN Healthcare (AMN) on its broad array of services.

Here's Why You Should Retain Baxter (BAX) Stock For Now

Investors continue to be optimistic about Baxter (BAX) due to its strong product portfolio.

Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio For Now

Investors remain optimistic about Abiomed (ABMD) due to strength in its Impella product line.

PerkinElmer's (PKI) Latest Launch to Boost Food Analysis Suite

PerkinElmer's (PKI) latest launch is likely to simplify the process of critical food analyses.

McKesson (MCK) Hits 52-Week High: What's Aiding the Stock?

Investors are optimistic about McKesson's (MCK) strength in its Biologics business.

Baxter (BAX) to Enhance Its Portfolio With Latest Partnership

Baxter's (BAX) latest strategic partnership with Digital Diagnostics is expected to expand its connected care diagnostics portfolio.

Here's Why You Should Retain Masimo (MASI) Stock For Now

Investors continue to be optimistic about Masimo (MASI) owing to its focus on patient monitoring.

Zacks Investment Ideas feature highlights: Allscripts Healthcare Solutions and Change Healthcare

Allscripts Healthcare Solutions and Change Healthcare are included in this investment ideas blog.

Reasons to Add Quidel (QDEL) Stock To Your Portfolio Now

Investors continue to be optimistic about Quidel (QDEL) owing to its strong diagnostics portfolio.

Allscripts (MDRX) Unveils Newly Rebranded App Expo Site

Allscripts' (MDRX) rebranded App Expo site to offer developers an opportunity to present their certified solutions online.

Reasons to Retain Catalent (CTLT) Stock in Your Portfolio

Catalent's (CTLT) robust facility expansion activities and a slew of strategic deals raise optimism on the stock.

Nevro's (NVRO) PDN Therapy Gets Noridian's Medicare Coverage

Latest favorable coverage decision for Nevro's (NVRO) PDN Therapy by Noridian is expected to allow the former to serve a wider patient pool.

Is Bayer Aktiengesellschaft (BAYRY) Outperforming Other Medical Stocks This Year?

Here is how Bayer Aktiengesellschaft (BAYRY) and AllScripts Healthcare (MDRX) have performed compared to their sector so far this year.

Allscripts (MDRX) Inks Divestment Deal to Focus on Core Wing

Constellation Software will purchase the net assets of Allscripts' (MDRX) Hospitals and Large Physician Practices business segment via its wholly-owned subsidiary.

Allscripts (MDRX) Up 4.5% Since Q4 Earnings: What's Driving It?

Allscripts' (MDRX) stock rallies on better-than-expected fourth-quarter performance and recent alliances.